Cargando…

Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure

BACKGROUND: Disturbances in the brain fluid balance can lead to life-threatening elevation in the intracranial pressure (ICP), which represents a vast clinical challenge. Nevertheless, the details underlying the molecular mechanisms governing cerebrospinal fluid (CSF) secretion are largely unresolve...

Descripción completa

Detalles Bibliográficos
Autores principales: Oernbo, Eva K., Steffensen, Annette B., Razzaghi Khamesi, Pooya, Toft-Bertelsen, Trine L., Barbuskaite, Dagne, Vilhardt, Frederik, Gerkau, Niklas J., Tritsaris, Katerina, Simonsen, Anja H., Lolansen, Sara D., Andreassen, Søren N., Hasselbalch, Steen G., Zeuthen, Thomas, Rose, Christine R., Kurtcuoglu, Vartan, MacAulay, Nanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422132/
https://www.ncbi.nlm.nih.gov/pubmed/36038945
http://dx.doi.org/10.1186/s12987-022-00358-4
_version_ 1784777747317391360
author Oernbo, Eva K.
Steffensen, Annette B.
Razzaghi Khamesi, Pooya
Toft-Bertelsen, Trine L.
Barbuskaite, Dagne
Vilhardt, Frederik
Gerkau, Niklas J.
Tritsaris, Katerina
Simonsen, Anja H.
Lolansen, Sara D.
Andreassen, Søren N.
Hasselbalch, Steen G.
Zeuthen, Thomas
Rose, Christine R.
Kurtcuoglu, Vartan
MacAulay, Nanna
author_facet Oernbo, Eva K.
Steffensen, Annette B.
Razzaghi Khamesi, Pooya
Toft-Bertelsen, Trine L.
Barbuskaite, Dagne
Vilhardt, Frederik
Gerkau, Niklas J.
Tritsaris, Katerina
Simonsen, Anja H.
Lolansen, Sara D.
Andreassen, Søren N.
Hasselbalch, Steen G.
Zeuthen, Thomas
Rose, Christine R.
Kurtcuoglu, Vartan
MacAulay, Nanna
author_sort Oernbo, Eva K.
collection PubMed
description BACKGROUND: Disturbances in the brain fluid balance can lead to life-threatening elevation in the intracranial pressure (ICP), which represents a vast clinical challenge. Nevertheless, the details underlying the molecular mechanisms governing cerebrospinal fluid (CSF) secretion are largely unresolved, thus preventing targeted and efficient pharmaceutical therapy of cerebral pathologies involving elevated ICP. METHODS: Experimental rats were employed for in vivo determinations of CSF secretion rates, ICP, blood pressure and ex vivo excised choroid plexus for morphological analysis and quantification of expression and activity of various transport proteins. CSF and blood extractions from rats, pigs, and humans were employed for osmolality determinations and a mathematical model employed to determine a contribution from potential local gradients at the surface of choroid plexus. RESULTS: We demonstrate that CSF secretion can occur independently of conventional osmosis and that local osmotic gradients do not suffice to support CSF secretion. Instead, the CSF secretion across the luminal membrane of choroid plexus relies approximately equally on the Na(+)/K(+)/2Cl(−) cotransporter NKCC1, the Na(+)/HCO(3)(−) cotransporter NBCe2, and the Na(+)/K(+)-ATPase, but not on the Na(+)/H(+) exchanger NHE1. We demonstrate that pharmacological modulation of CSF secretion directly affects the ICP. CONCLUSIONS: CSF secretion appears to not rely on conventional osmosis, but rather occur by a concerted effort of different choroidal transporters, possibly via a molecular mode of water transport inherent in the proteins themselves. Therapeutic modulation of the rate of CSF secretion may be employed as a strategy to modulate ICP. These insights identify new promising therapeutic targets against brain pathologies associated with elevated ICP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00358-4.
format Online
Article
Text
id pubmed-9422132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94221322022-08-30 Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure Oernbo, Eva K. Steffensen, Annette B. Razzaghi Khamesi, Pooya Toft-Bertelsen, Trine L. Barbuskaite, Dagne Vilhardt, Frederik Gerkau, Niklas J. Tritsaris, Katerina Simonsen, Anja H. Lolansen, Sara D. Andreassen, Søren N. Hasselbalch, Steen G. Zeuthen, Thomas Rose, Christine R. Kurtcuoglu, Vartan MacAulay, Nanna Fluids Barriers CNS Research BACKGROUND: Disturbances in the brain fluid balance can lead to life-threatening elevation in the intracranial pressure (ICP), which represents a vast clinical challenge. Nevertheless, the details underlying the molecular mechanisms governing cerebrospinal fluid (CSF) secretion are largely unresolved, thus preventing targeted and efficient pharmaceutical therapy of cerebral pathologies involving elevated ICP. METHODS: Experimental rats were employed for in vivo determinations of CSF secretion rates, ICP, blood pressure and ex vivo excised choroid plexus for morphological analysis and quantification of expression and activity of various transport proteins. CSF and blood extractions from rats, pigs, and humans were employed for osmolality determinations and a mathematical model employed to determine a contribution from potential local gradients at the surface of choroid plexus. RESULTS: We demonstrate that CSF secretion can occur independently of conventional osmosis and that local osmotic gradients do not suffice to support CSF secretion. Instead, the CSF secretion across the luminal membrane of choroid plexus relies approximately equally on the Na(+)/K(+)/2Cl(−) cotransporter NKCC1, the Na(+)/HCO(3)(−) cotransporter NBCe2, and the Na(+)/K(+)-ATPase, but not on the Na(+)/H(+) exchanger NHE1. We demonstrate that pharmacological modulation of CSF secretion directly affects the ICP. CONCLUSIONS: CSF secretion appears to not rely on conventional osmosis, but rather occur by a concerted effort of different choroidal transporters, possibly via a molecular mode of water transport inherent in the proteins themselves. Therapeutic modulation of the rate of CSF secretion may be employed as a strategy to modulate ICP. These insights identify new promising therapeutic targets against brain pathologies associated with elevated ICP. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12987-022-00358-4. BioMed Central 2022-08-29 /pmc/articles/PMC9422132/ /pubmed/36038945 http://dx.doi.org/10.1186/s12987-022-00358-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Oernbo, Eva K.
Steffensen, Annette B.
Razzaghi Khamesi, Pooya
Toft-Bertelsen, Trine L.
Barbuskaite, Dagne
Vilhardt, Frederik
Gerkau, Niklas J.
Tritsaris, Katerina
Simonsen, Anja H.
Lolansen, Sara D.
Andreassen, Søren N.
Hasselbalch, Steen G.
Zeuthen, Thomas
Rose, Christine R.
Kurtcuoglu, Vartan
MacAulay, Nanna
Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title_full Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title_fullStr Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title_full_unstemmed Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title_short Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
title_sort membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422132/
https://www.ncbi.nlm.nih.gov/pubmed/36038945
http://dx.doi.org/10.1186/s12987-022-00358-4
work_keys_str_mv AT oernboevak membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT steffensenannetteb membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT razzaghikhamesipooya membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT toftbertelsentrinel membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT barbuskaitedagne membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT vilhardtfrederik membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT gerkauniklasj membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT tritsariskaterina membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT simonsenanjah membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT lolansensarad membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT andreassensørenn membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT hasselbalchsteeng membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT zeuthenthomas membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT rosechristiner membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT kurtcuogluvartan membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure
AT macaulaynanna membranetransporterscontrolcerebrospinalfluidformationindependentlyofconventionalosmosistomodulateintracranialpressure